July 1, 2026
Trailhead Biosystems Expands iPSC Derived Cell Portfolio with TrailBio® Endothelial Cells
B iPSC-derived endothelial cells support vascular biology, drug discovery and toxicity studies BEACHWOOD, Ohio, April 28, 2026 /PRNewswire/ — Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology…
